{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:13:39Z","timestamp":1777864419447,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1053\/j.ajkd.2023.12.002","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T01:39:26Z","timestamp":1705455566000},"page":"288-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulation for Atrial Fibrillation in Advanced CKD: Can Observational Studies Provide the Answer?"],"prefix":"10.1053","volume":"83","author":[{"given":"Daniel E.","family":"Weiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2023.12.002_bib1","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.002_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225052","article-title":"Clinical outcomes and treatment patterns among Medicare patients with nonvalvular atrial fibrillation (NVAF) and chronic kidney disease","volume":"14","author":"Wilson","year":"2019","journal-title":"PLoS One"},{"issue":"4 suppl 1","key":"10.1053\/j.ajkd.2023.12.002_bib3","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 Annual Data Report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.002_bib4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.002_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2023.12.002_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.ajkd.2023.08.017","article-title":"Comparative safety and effectiveness of warfarin or rivaroxaban versus apixaban in patients with advanced CKD and atrial fibrillation: nationwide US cohort study","volume":"83","author":"Fu","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.002_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100675","article-title":"Safety and effectiveness of rivaroxaban versus warfarin across GFR levels in atrial fibrillation: a population-based study in Australia and Canada","volume":"5","author":"Ha","year":"2023","journal-title":"Kidney Med"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.002_bib8","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"17","key":"10.1053\/j.ajkd.2023.12.002_bib9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.119.044059","article-title":"Apixaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease","volume":"141","author":"Stanifer","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1053\/j.ajkd.2023.12.002_bib10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jacc.2016.11.074","article-title":"Apixaban dosing in chronic kidney disease: differences between U.S. and E.U. labeling","volume":"69","author":"Brophy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1053\/j.ajkd.2023.12.002_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCULATIONAHA.123.065614","article-title":"Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease","volume":"148","author":"Xu","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100686","article-title":"Anticoagulation in CKD: trials and tribulations","volume":"5","author":"Mohsen","year":"2023","journal-title":"Kidney Med"},{"issue":"5","key":"10.1053\/j.ajkd.2023.12.002_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2125.2010.03753.x","article-title":"Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor","volume":"70","author":"Kubitza","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100646","article-title":"Pharmacokinetics of apixaban among peritoneal dialysis patients","volume":"5","author":"Fung","year":"2023","journal-title":"Kidney Med"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.002_bib15","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623009599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623009599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:50:06Z","timestamp":1759463406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623009599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272638623009599"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.002","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation for Atrial Fibrillation in Advanced CKD: Can Observational Studies Provide the Answer?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}